ARCHIVES

In Brief: Kamen Named ACS Professor; Bordon Moves To Univ. Of Maryland As Center Director Mars-Cassell Report Urged formation Of Advisory Committee

This article is from The Cancer Letter archive.

Vol. 20 No. 31 | August 5, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Plans to Discuss the Negative Trial of AstraZeneca’s Drug Iressa With the Oncologic Drugs Advisory Committee in March.

January 21, 2005

DCPC Advisors Begin Process Of Setting Priorities For Research

June 21, 1991

NCI Tightens Monitoring, Upgrades Staff Training In Attempts To Improve Management Of Contracts

January 9, 1981

FDA Proposes New User Fees for Generics and Biosimilar Products

January 20, 2012

Includes June issue of Business & Regulatory Report.

June 28, 2002

ASCO Urges NCI To Spell Out Metrics of Success Beyond Cutting Groups to Arbitrary Number

June 17, 2011